Durvalumab shows promising results in trial led by London-based Institute of Cancer Research ...

SURGERY to remove the bladder of cancer patients could be avoided in thousands of cases thanks to a new drug combination.

“By adding immunotherapy to chemotherapy and radiotherapy, we may be able to spare patients the physical and psychological ...

An eight-year Indian clinical trial shows that radiation therapy after bladder removal surgery can significantly reduce ...

The authors underscored the potential of adjuvant pelvic IMRT (post-surgery pelvic radiation therapy) to enhance locoregional ...

A 72-year-old man with multiple health issues, including diabetes and psoriasis, successfully underwent complex bladder ...

Patients with early-stage bladder cancer are often able to maintain their usual routines. Some may experience urinary ...

Aleksandar Alchev is a Director of Business Development at Minnesota Urology, overseeing the practice’s In-Office Dispensary, Prostate Cancer Navigation, Cancer Center Operations, and Men’s Health ...

For people with non–muscle invasive bladder cancer (NMIBC), the reality can be especially pronounced. The disease is often persistent, requiring repeated treatments, frequent monitoring, and ongoing ...

What Is It, and Why Does It Matter? Tecentriq (atezolizumab) and Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs) are prescription immunotherapy medicines used to help the body's immune system ...